Home / Inspections / 961406

FDA Inspection 961406 — Elite Laboratories Inc.

Elite Laboratories Inc. — FEI 3002644678

The FDA completed an inspection of Elite Laboratories Inc. on February 2, 2016 in Northvale, NJ. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
February 2, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Northvale, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Facility

Other inspections at this facility

  • 1269549 (VAI Fri Aug 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1120647 (VAI Fri Mar 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1119158 (NAI Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1042332 (NAI Fri Feb 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1038658 (NAI Mon Dec 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources